29 July 2025 : Original article
Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance
Dong Hui ShinDOI: 10.12659/AOT.947747
Ann Transplant 2025; 30:e947747
Table 3 Baseline characteristics.
| Variable | Delayed steroid withdrawal (n=14) | Rapid steroid withdrawal (n=6) | P value |
|---|---|---|---|
| Age (years) | 50.6±8.6 | 48.2±13.5 | 0.636 |
| Sex, male | 7 (50.0) | 2 (33.3) | 0.492 |
| BMI (kg/m) | 24.1±2.4 | 22.1±3.5 | 0.154 |
| Year of KT | 0.091 | ||
| 2014–2017 | 5 (35.7) | 0 (0.0) | |
| 2018–2021 | 9 (64.3) | 6 (100) | |
| Re-transplantation | 1 (7.1) | 0 (0.0) | 0.502 |
| Cause of ESKD | 0.609 | ||
| DM | 6 (42.9) | 2 (33.3) | |
| Hypertension | 2 (14.3) | 1 (16.7) | |
| Glomerular disease | 4 (28.6) | 1 (16.7) | |
| PCKD | 0 (0.0) | 1 (16.7) | |
| Unknown | 2 (14.3) | 1 (16.7) | |
| Dialysis duration (months) | 9.6±11.3 | 30.8±46.7 | 0.113 |
| DM | 8 (57.1) | 2 (33.3) | 0.329 |
| CVD | 1 (7.1) | 0 (0.0) | 0.502 |
| Donor type | 0.389 | ||
| Parent | 1 (7.1) | 2 (33.3) | |
| Offspring | 4 (28.6) | 1 (16.7) | |
| Sibling | 1 (7.1) | 1 (16.7) | |
| Spouse | 8 (57.1) | 2 (28.6) | |
| Other unrelated | 0 (0.0) | 0 (0.0) | |
| Donor age (years) | 45.2±14.7 | 53.5±12.9 | 0.249 |
| Donor sex, male | 6 (42.9) | 5 (83.3) | 0.095 |
| Donor BMI (kg/m) | 25.3±3.0 | 26.2±3.0 | 0.546 |
| Donor creatinine at donation (mg/dL) | 0.84±0.12 | 0.90±0.21 | 0.405 |
| Donor HTN | 5 (35.7) | 2 (33.3) | 0.919 |
| Donor DM | 0 (0.0) | 1 (16.7) | 0.117 |
| CIT (min) | 77.7±20.7 | 73.3±15.4 | 0.649 |
| HLA mismatch | 4.1±1.5 | 3.3±0.8 | 0.287 |
| Induction agent | 0.001 | ||
| IL-2 receptor antibody | 3 (21.4) | 6 (100) | |
| Anti-thymocyte globulin | 11 (78.6) | 0 (0.0) | |
| Prescription of valganciclovir at discharge | 7 (50.0) | 0 (0.0) | 0.032 |
| Data are expressed as mean±standard deviation or number (%). BMI – body mass index; CIT – cold ischemic time; CVD – cardiovascular disease; DM – diabetes mellitus; ESKD – end-stage kidney disease; HLA – human leukocyte antigens; HTN – hypertension; KT – kidney transplant; PCKD – polycystic kidney disease. | |||






